DENVER, Colo., Nov 12, 2025 (247marketnews.com)- The final trading hour of Wednesday’s session is shaping up to be a sprint to the finish line as investors pile into biotech, AI, and clean-tech names on strong earnings, corporate catalysts, and heavy volume.
Wearable Devices (NASDAQ:WLDS)- Neural Interface Innovator Extends Rally
Wearable Devices– a leader in neural input technology enabling gesture-based control, is moving higher again this afternoon.
The company’s Mudra Band technology, which integrates with Apple Watch and AR/VR platforms, continues to attract attention from both retail and institutional investors. With increasing interest in human-computer interface stocks, WLDS has emerged as a speculative favorite into the year’s close.
On Holding (NYSE:ONON)- Runs Past Expectations, Raises Full-Year Outlook
Swiss performance footwear and apparel brand On Holding AG surged after a record quarter with net sales up 24.9% year-over-year to CHF 794.4 million and gross margin expanding to a record 65.7%.
The company lifted its full-year growth forecast to 34% in constant currency and projected CHF 2.98 billion in reported net sales, buoyed by rapid expansion in apparel (+86.9%) and global retail presence. Co-founder Caspar Coppetti said the brand’s success lies in its “combination of innovation and cultural relevance,” as On cements its place in the premium athletic market.
Kraig Labs (OTCQB:KBLB)- Commercial Spider Silk Era Nears Launch
Kraig Labs is the world’s leading spider silk developer and the conventional wisdom is that spider silk will unlock new wearables and performance gear, in addition to many other applications. Anticipation is currently building for the company’s first commercial shipments of recombinant spider silk fiber and fabric to its global partners.
Leveraging a proprietary gene-editing platform that allows silkworms to spin spider silk, branded Dragon Silk
and Monster Silk®, Kraig stands alone in an industry that has eluded scalability for decades. With potential applications across defense, fashion, and high-performance materials, KBLB continues to attract early interest from long-term investors awaiting validation through real-world orders.
Abeona Therapeutics (NASDAQ:ABEO)- Gene Therapy Leader Extends Gains on Regulatory Momentum
Shares of Abeona Therapeutics are on the move again after investors continued to digest the company’s regulatory milestones tied to its EB-101 cell therapy for recessive dystrophic epidermolysis bullosa (RDEB). The stock has been trending higher since the FDA’s earlier approval and subsequent manufacturing updates.
Traders are keeping an eye on after-hours action as Abeona remains a favorite among gene-therapy investors for its expanding rare-disease pipeline and cleaner balance sheet post-commercial launch preparations.
Centessa Pharmaceuticals (NASDAQ:CNTA)- Pipeline Updates Spark Renewed Interest
Centessa Pharmaceuticals continues to attract institutional attention after a string of positive program updates across its SerpinPC and ORX750 programs. The company’s unique asset-centric model and recent early-stage clinical results are drawing fresh interest from long-term biotech funds.
With analysts highlighting Centessa’s cash runway into 2027 and multiple readouts expected in 2026, CNTA remains a name to watch into the biotech rebound that’s been quietly gaining strength this quarter.
Relmada Therapeutics (NASDAQ:RLMD)- Depression Drug Data Drives High-Volume Rebound
Relmada Therapeutics is rallying sharply this afternoon after traders circulated new analysis of its late-stage REL-1017 (esmethadone) program for major depressive disorder. The company’s investor presentation at a recent healthcare conference reignited optimism about its Phase 3 timeline and potential partnership interest.
While volatility remains high, RLMD has been one of the most heavily traded small-cap biotech names this week, with speculative interest picking up into the close.
BigBear.ai Holdings (NYSE:BBAI) — AI Intelligence Firm Strengthens Pipeline, Draws Retail Flow
BigBear.ai Holdings is pushing higher on increased retail volume, building on its recent momentum following new U.S. government contract awards and artificial intelligence platform enhancements.
The company continues to position itself as a dual-play AI defense and analytics provider. Investors are watching to see if BBAI can sustain a move above $1.50, a level that’s acted as a ceiling since summer.
Creative Media & Community Trust (NASDAQ:CMCT) — Asset Sale Highlights Realignment Strategy
CMCT shares remain active after the company confirmed its $44 million divestiture of its lending division to an affiliate of Peachtree Group, expected to generate $31 million in net proceeds.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
For more information, please visit: www.kraiglabs.com
Contact [email protected] for Analyst Report coverage and other investor/public relations services.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
The post Biotech Breakouts, AI Momentum, and Athletic Triumphs- Stocks to Watch as Markets Race Toward the Close appeared first on 24/7 MarketNews.